The latest market report published by Acute Market Reports “Global Breast Imaging Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026,” the global breast imaging market was valued at US$ 2,334.2 Mn in 2017, and is expected to reach US$ 4,945.3 Mn by 2026, expanding at a CAGR of 8.7% from 2018 to 2026.
Market Insights
According to American Cancer Society (ACS), research findings breast cancer is typically manifested with no symptoms when the tumor is small which makes early detection of prime importance. The most com+++mon physical symptom is a painless lump. In certain cases, cancer spreads in the lymph nodes present in the underarms region. The other symptoms related to breast cancer are breast pain, thickening, and nipple abnormalities such as erosion & blood discharge. Breast cancer is classified on the basis of location and aggressiveness of the disease. Ductal carcinoma is the most common type which occurs within the ducts that transport milk to the nipple. Metastatic breast cancer, inflammatory breast cancer, and triple-negative breast cancer are the other types of breast cancer occurring in the women population. The occurrence is highly variable in different ethnic and racial groups throughout the globe.
Browse the full report Breast Imaging Market – Growth, Future Prospects, Competitive Analysis, 2018 – 2026 at https://www.acutemarketreports.com/report/breast-imaging-market
Mammography is still considered the most preferred equipment for the diagnosis of breast cancer. The limitations associated with mammography are the false positive and false negative inferences which result in more diagnostic tests and follow-up visits which become stressful for the ailing patient. Tomosynthesis is the advanced version of mammography which provides high-resolution 3D images of breast-related diseases. Breast ultrasound will register rapid growth during the forecast period 2018 to 2026 on account of key parameters such as high resolution, better patient compliance during diagnosis, and safety in pregnant women & women with breast implants as there is no risk of radiation exposure.
In the present scenario, North America is leading the regional segment owing to key factors such as the rising prevalence of breast cancer in the women population availing hormone replacement therapy. The domicile of market leaders in the breast imaging devices such as Philips Healthcare and Siemens Healthcare GmbH drive the market growth in Europe. The Asia Pacific is set to register impressive growth during the forecast period on account of proactive government initiatives to educate women regarding breast cancer and implementing effective diagnosis at primary healthcare centers. The Middle East & Africa and Latin America serve as a lucrative market for key players to promote business expansion through inorganic and organic market growth strategies.
The market leaders that influence the breast imaging market growth are Aurora Imaging Technology, Inc., Dilon Technologies, Inc., Fujifilm Holding Corporation, GE Healthcare, Gamma Medica, Inc., Hologic, Inc., Philips Healthcare, Sonocine, Inc., Toshiba Corporation, and Siemens Healthcare GmbH.
Key Market Movements:
• Rising prevalence of breast cancer and increasing public health awareness regarding cancer chemotherapy and its adverse effects
• Supportive regulatory environment for the market growth of breast imaging devices
• Technological advancement in the ergonomics and diagnosis parameters installed in the breast imaging devices
The Global Breast Imaging Market is Segmented into:
| ATTRIBUTE | DETAILS |
|---|---|
| Research Period | 2016-2026 |
| Base Year | 2017 |
| Forecast Period | 2018-2026 |
| Historical Year | 2016 |
| Unit | USD Million |
| Segmentation | By Technology Type (2016–2026; US$ Mn) |
| Geography Segment (2016–2026; US$ Mn) |
*Complete segmentation list is on a report page
About Us
Acute Market Reports is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives.
Contact
Acute Market Reports
Address: 90 Church St, FL 1 #3514,
New York, NY 10008 United States
Toll Free(US/CANADA): +1-855-455-8662
E-mail: sales@acutemarketreports.com
